Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lawrence Waldman currently holds 50,000 shares of Apyx Medical Corp (APYX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence Waldman has been a net neutral trader of APYX stock. They have purchased $0 and sold $0 worth of shares.
Lawrence Waldman's most recent insider trade was on Jun 11, 2026, when they sold 50,000 shares at $0.00 per share.
Lawrence Waldman serves as Executive at Apyx Medical Corp (APYX). They have executed 22 insider transactions totaling $0 over their tenure at the company.
Lawrence Waldman holds the position of Executive at Apyx Medical Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Lawrence Waldman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Lawrence Waldman was on Oct 22, 2018, when they sold $102.6K worth of NONE shares. This transaction involved 11,163 shares at $9.19 per share.
Lawrence Waldman currently owns 50,000 shares of Apyx Medical Corp (APYX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lawrence Waldman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lawrence Waldman has 22 Form 4 filings on record as an insider at Apyx Medical Corp.
Set alerts for Lawrence Waldman and 40,000+ other insiders.